M. Filicori et al., INCREASED INSULIN-SECRETION IN PATIENTS WITH MULTIFOLLICULAR AND POLYCYSTIC OVARIES AND ITS IMPACT ON OVULATION INDUCTION, Fertility and sterility, 62(2), 1994, pp. 279-285
Objective: to assess the oral glucose tolerance test (OGTT)-stimulated
insulin secretion and its relation to pulsatile GnRH ovulation induct
ion outcome in patients with multifollicular or polycystic ovaries (PC
Os). Design: Prospective study. Setting: Reproductive Endocrinology Ce
nter, University of Bologna, Bologna, Italy. Patients: Eight normal an
d 29 anovulatory women (8 with multifollicular ovaries and 21 with PCO
s). Intervention: A stnadard OGTT was performed in all subjects. In al
l anovulatory patients, ovulation was induced with pulsatile GnRH (5 m
u g IV every 60 minutes). In multifollicular ovary patients, pulsatile
GnRH was administered alone, whereas in PCOs it was preceded by GnRh
agonist (GnRH-a) suppression. Main Outcome Measures: Glucose, insulin,
and C-peptide response to the OGTT, expressed as area under the curve
(AUC). Ovulatory rates in response to pulsatile GnRH. Results: Insuli
n and C-peptide AUC were greater than controls in both multifollicular
ovary and PCO patients. Insulin AUC was positively correlated to ovar
ian volume. Ovulation was achieved in 88% and 57% of multifollicular o
vary and PCO patients, respectively. Body mass index and glucose AUC b
ut not insulin and C-peptide AUC were significantly greater in the ano
vulatory PCO. Conclusions: [1] insulin AUC was increased in both multi
follicular ovary and PCO patients; [2] derangements of insulin secreti
on may be present in a greater variety of anovulatory patients than pr
eviously thought; [3] insulin levels during the OGTT did not predict a
response to pulsatile GnRH in PCOs, suggesting complex insulin intera
ctions of the ovarian level; [4] given the in vitro stimulatory proper
ties of insulin of granulosa cells synergistic with FSH, we propose th
at excessive insulin levels may may contribute to the ovarian enlargem
ent often bound in multifollicular ovary and PCO patients.